Ixekizumab reduces erosion and increases backfill in the sacroiliac joints of patients with radiographic axial ...

Celltrion, a major Korean biopharmaceutical firm, said Tuesday that its two new biosimilars for bone disease treatment, Stoboclo and Osenvelt, have obtained approval from the United States.

Greek yogurt and cottage cheese may support health in several ways. However, there are some nutritional differences between ...

For patients with a rare genetic disorder that turns their muscles into bone, there is new hope. The disease is […] ...

Naxitamab demonstrated clinically meaningful efficacy with manageable safety in patients with relapsed/refractory high-risk neuroblastoma and residual disease in bone/bone marrowNEW YORK, March 03, ...